You are here

  • Home
  • Archive
  • Volume 13, Issue 4
  • Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

https://doi.org/10.1136/jitc-2021-003982corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Zhang X, Lao M, Xu J, et al. Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. J Immunother Cancer 2022;10:e003982. doi: 10.1136/jitc-2021–003982

    This article has been corrected since it was first published online. Figure 4D was updated as the original image for the Panc02 panel was inadvertently mislabeled during figure assembly. In addition this figure 7E was updated as the CD4+T cell proportion graph in figure 7C was erroneously duplicated in figure 7E.